In hematopoietic malignancies, FBXW7 has been identified as a tumor suppressor for its ability to mediate proto-oncogene protein degradation in T-cell acute lymphoblastic leukemia (16). This evidence concerns the gene FBXW7 and T-cell acute lymphoblastic leukemia.